Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Argus Health
Deloitte
McKinsey
Queensland Health
Colorcon
Baxter
Citi
Chubb

Generated: June 20, 2018

DrugPatentWatch Database Preview

ACEPHEN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Acephen, and when can generic versions of Acephen launch?

Acephen is a drug marketed by G And W Labs and is included in four NDAs.

The generic ingredient in ACEPHEN is acetaminophen. There are sixty-six drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
Summary for ACEPHEN
Drug patent expirations by year for ACEPHEN
Medical Subject Heading (MeSH) Categories for ACEPHEN

US Patents and Regulatory Information for ACEPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072218-001 Mar 27, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-003 Dec 18, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-001 Approved Prior to Jan 1, 1982 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072344-001 Mar 27, 1992 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Johnson and Johnson
US Department of Justice
Cerilliant
McKinsey
Deloitte
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.